近期，一则‘5元疫苗打不动，200元流感药抢着要’的现象引发社会广泛关注。这句话形象地揭示了当前公众在疾病预防与治疗之间的认知偏差和行为矛盾。一方面，价格低廉、效果明确的国产流感疫苗（如单价仅5元左右）接种率长期偏低，很多人因担心副作用、认为‘没必要’或对疫苗效果存疑而拒绝接种；另一方面，一旦感染流感，人们却愿意花高价（如200元一盒的抗病毒药物奥司他韦）抢购治疗药品，甚至出现断货现象。这种‘重治疗、轻预防’的倾向，不仅增加了个人医疗支出，也加重了公共卫生系统的负担。事实上，接种流感疫苗是预防流感最经济、最有效的手段，不仅能显著降低感染风险，还能减轻症状严重程度。相比之下，抗病毒药物虽有一定疗效，但需在发病48小时内使用才有效，且不能替代疫苗的预防作用。专家呼吁，应加强健康科普教育，提升公众对疫苗科学性的认知，改变‘贵的就是好的’‘有病才治’等误区。同时，完善疫苗接种服务体系，提高便利性和可及性，才能真正实现从‘被动治疗’向‘主动预防’的转变。
Recently, a phenomenon described as ‘People won’t get a 5-yuan flu vaccine, but rush to buy 200-yuan flu medication’ has drawn widespread public attention. This phrase vividly highlights the cognitive bias and behavioral contradiction in how people approach disease prevention versus treatment. On one hand, affordable and effective domestic flu vaccines—some costing as little as 5 RMB—are consistently underutilized, as many avoid them due to concerns about side effects, perceived lack of necessity, or doubts about efficacy. On the other hand, once infected with influenza, people are quick to spend heavily—sometimes over 200 RMB per box—for antiviral drugs like oseltamivir, often causing shortages.This ‘treatment-first, prevention-later’ mindset not only increases individual healthcare costs but also burdens the public health system. In reality, flu vaccination remains the most cost-effective and efficient way to prevent influenza, significantly reducing infection risk and symptom severity. Antiviral medications, while helpful, are only effective if taken within 48 hours of symptom onset and cannot replace the preventive power of vaccines.Experts urge stronger public health education to improve scientific understanding of vaccines and dispel misconceptions such as ‘expensive equals better’ or ‘only treat when sick.’ Enhancing vaccine accessibility and convenience is essential to shift society from reactive treatment to proactive prevention.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/5405.html